MAXYGEN INC - FORM 8-K - May 31, 2011
| Attached files | ||||||
| File | Filename | |||||
|---|---|---|---|---|---|---|
| EX-99.1 - PRESS RELEASE - MAXYGEN INC | dex991.htm | |||||
| People who read this document also read: | ||||||
| Document | ||||||
|---|---|---|---|---|---|---|
| MIPS TECHNOLOGIES INC - 8-K, Results of Operations and Financial Condition Financial Statements and Exhibits | ||||||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 27, 2011
Maxygen, Inc.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 000-28401 | 77-0449487 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
515 Galveston Drive
Redwood City, CA 94063
(Address of Principal Executive Offices)
(650) 298-5300
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
Maxygen, Inc. (the “Company”) held its Annual Meeting of Stockholders on May 27, 2011. The following is a summary of the matters voted on at that meeting.
| (a) | The Company’s stockholders reelected the six nominees for the Company’s board of directors. The persons elected to the Company’s board of directors and the number of shares cast for, the number of shares withheld, and broker non-votes, with respect to each of these persons, were as follows: |
| Name |
Votes For |
Votes Withheld |
Broker Non-Votes | |||
| Louis G. Lange |
14,170,082 | 421,690 | 8,036,045 | |||
| Kenneth B. Lee, Jr. |
14,375,290 | 216,482 | 8,036,045 | |||
| Ernest Mario |
14,028,567 | 563,205 | 8,036,045 | |||
| Gordon Ringold |
14,344,990 | 246,782 | 8,036,045 | |||
| Isaac Stein |
14,410,389 | 181,383 | 8,036,045 | |||
| James R. Sulat |
13,950,419 | 641,353 | 8,036,045 |
| (b) | The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011. The number of shares cast in favor of the ratification of Ernst & Young LLP, the number against, the number abstaining, and broker non-votes were as follows: |
| For |
Against |
Abstain |
Broker Non-Votes | |||
| 22,494,885 |
101,972 | 30,960 | 0 |
| (c) | The Company’s stockholders voted to approve the compensation of the Company’s named executive officers listed in the proxy statement for the 2011 annual meeting. The stockholder vote is advisory and non-binding. The number of shares cast in favor of approval, the number against, the number abstaining, and the number of broker non-votes were as follows: |
| For |
Against |
Abstain |
Broker Non-Votes | |||
| 13,734,278 |
156,194 | 701,300 | 8,036,045 |
| (d) | The Company’s stockholders voted to approve management’s recommendation that the Company present stockholders with the opportunity to vote on the compensation awarded to its named executive officers annually. The stockholder vote is advisory and non-binding. The number of shares cast in favor of holding the vote annually, every two years or every three years, the number abstaining and the number of broker non-votes were as follows: |
| Annual |
Every 2 Years |
Every 3 Years |
Abstain |
Broker Non-Votes | ||||
| 11,637,813 |
14,237 | 2,222,914 | 716,808 | 8,036,045 |
| Item 8.01 | Other Events. |
On May 31, 2011, the Company issued a press release announcing a $10.0 million stock repurchase program. The press release is attached as Exhibit 99.1 and is incorporated herein by reference.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits |
| Exhibit |
Description | |
| 99.1 | Press Release, dated May 31, 2011 entitled “Maxygen Announces $10 Million Stock Repurchase Program.” | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MAXYGEN, INC. | ||||||
| (Registrant) | ||||||
| Date: May 31, 2011 | ||||||
| /s/ James Sulat | ||||||
| (Signature) | ||||||
| Name: | James Sulat | |||||
| Title: | Chief Executive Officer | |||||
User Contributions:
Comment about this document or add new information about this topic:
This web site and associated pages are not associated with, endorsed by, or sponsored by MAXYGEN INC and has no official or unofficial affiliation with MAXYGEN INC
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
